Can RAD1901 Be Used in Breast Cancer Patients with ESR1 Mutations

    Share on Google+        
Can RAD1901 Be Used in Breast Cancer Patients with ESR1 Mutations
Click on the image
Description: Aditya Bardia, MD, MPH of Harvard Medical School and Massachusetts General Hospital Cancer Center discusses common questions he's asked regarding his study on the use of elacestrant (RAD1901) for ER+ advanced breast cancer. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.

About Us
posted-today.org shows the most important world news of the day, under the editorial criteria of their impact on Internet and social networks.
Contact
Do you have any suggestion? Contact us.

    Share on Google+        

We might need you!
Investors and business angels continue reading, please: posted-today.org is a very innovative project which has just started. We can steadily grow in visits and content and become leaders of the digital press in an ETA of 10 years. This curve of success could be considerably improved having more resources. If you stand out for your vision of the future, maybe you can help us, or the other way round.
Technology
This is not just buzzing words: posted-today.org is an example of what you get when applying state-of-the-art technologies, such as Big Data, Content Curation, Natural Language Processing (NLP), NoSQL, Cloud Computing, ...